Interferon therapy for vascular tumors of bone

Current Opinion in Orthopaedics

Volumn 12, Issue 6, 2001, Pages 514-518

  Yasko, Alan W ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANGIOGENESIS INHIBITOR; INTERFERON;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; BONE METASTASIS; BONE TUMOR; DRUG MECHANISM; GIANT CELL TUMOR; HEMANGIOMA; HUMAN; PRIORITY JOURNAL; REVIEW; SOLID TUMOR; VASCULAR TUMOR;

EID: 0035161490     PISSN: 10419918     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001433-200112000-00014     Document Type: Review

References (27)

1. Clinical applications of research on angiogenesis
2. Dormancy of micrometastases; balanced proliferation and apoptosis in the presence of angiogenesis suppression
3. Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas
4. Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration
5. Interferon-α-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule
6. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon
7. Expression of basic fibroblast growth factor protein and its down-regulation by interferons in head and neck cancer
8. Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-beta
9. Inhibition of angiogenesis and vascular tumor growth by interferon-producing cells: A gene therapy approach
10. Treatment of childhood angiomatous diseases with recombinant interferon alfa-2a
11. Interferon alfa-2a therapy for life threatening hemangiomas of infancy
12. Treatment of haemangioendotheliomas with alpha interferon
13. Kaposi's sarcoma and the acquired immune deficiency syndrome: Treatment with high and low doses of recombinant leucocyte A interferon
14. Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a
15. Recombinant interferon alfa-2b in the treatment of vision-threatening capilary hemangiomas in childhood
16. Complete regression of retinal neovascularization after therapy with interferon alfa in Behcet's disease
17. Does successful interferon treatment of tumor patients require life-long treatment?
18. Generalized giant-cell tumour of bone: Successful treatment of pulmonary metastases with interferon alpha, a case report
19. Antiangiogenic therapy of a recurrent giant cell tumor of the mandible with interferon alfa-2a
20. Interferon α-2b at low doses as long-term antiangiogenic treatment of a metastatic intracranial hemangioendothelioma: A case report
21. Metastases from histologically benign giant cell tumors of bone
22. Long-term adjuvant interferon treatment of human osteosarcoma. A pilot study
23. Interferon-alpha enhances the sensitivity of human osteosarcoma cells to etoposide
24. Establishment and characterization of a murine osteosarcoma cell line (LM8) with high metastatic potential to the lung
25. Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma
26. Gene expression of vascular endothelial growth factor in giant cell tumors of bone
27. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis